LGHTLangar Global Healthtech ETF
Seeks long-term growth of capital.
By Langar Funds · Launched 2024
Annual Cost
0.85%
#4,507 of 5,854 · expensive
Fund Size
$2M
#5,438 of 5,854 · small
Return (1Y)Goal
-17.4%
Track Record
2 years
#3,313 of 5,854 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$8,570-14.3%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 62.2% of fundconcentrated
Intuitive Surgical I
13.1%
ResMed Inc
8.8%
GE HealthCare
7.8%
Veeva Systems Inc
5.6%
Insulet Corp
5.0%
Koninklijke Philips
4.7%
IQVIA Holdings Inc
4.5%
Siemens Healthineers
4.5%
Zimmer Biomet Holdin
4.3%
DEXCOM INC COM
3.9%
Asset allocation
Stocks
83.2%
Cash
16.8%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
20.5%High
Year-on-year price swings
Max drawdown
-28.6%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NYSE Arca, Cboe BZX
Full fund details
- Objective
- Seeks long-term growth of capital.
- Strategy
- Actively manages a portfolio primarily invested in U.S. and foreign exchange-listed equity securities of healthcare technology companies, which may be of any market capitalization. Focuses on companies that develop technology to create efficiencies in healthcare, addressing key pain points for patients and providers.
- Inception date
- January 11, 2024
- Fund family
- Langar Funds
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at LGHT. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-03